Variation in Antibiotic Prescription in High-Risk Febrile Neutropenia in Portuguese Hospitals

被引:0
|
作者
Freitas, Marta [1 ]
Andrade, Paulo [2 ,3 ]
Pinto, Ricardo [4 ]
Trigo, Fernanda [4 ]
Azevedo, Ana [1 ,5 ,6 ]
Almeida, Francisco [1 ,2 ,6 ]
机构
[1] Univ Porto, Fac Med, Alameda Prof Hernani Monteiro, P-4200039 Porto, Portugal
[2] Unidade Local Saude Sao Joao, Ctr Epidemiol Hosp, Unidade Prevencao & Controlo Infecao & Resistencia, P-4200319 Porto, Portugal
[3] Unidade Local Saude Sao Joao, Serv Doencas Infecciosas, P-4200319 Porto, Portugal
[4] Unidade Local Saude Sao Joao, Serv Hematol Clin, P-4200319 Porto, Portugal
[5] Unidade Local Saude Sao Joao, Ctr Epidemiol Hosp, P-4200319 Porto, Portugal
[6] Univ Porto, Inst Saude Publ, Lab Invest Integrat & Translac Saude Populac ITR, EPIUnit, P-4050600 Porto, Portugal
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 09期
关键词
febrile neutropenia; high risk; antimicrobial stewardship; survey; guidelines; INFECTIOUS-DISEASES SOCIETY; CLINICAL-PRACTICE GUIDELINE; OUTPATIENT MANAGEMENT; FEVER; RESISTANCE; ONCOLOGY; THERAPY;
D O I
10.3390/antibiotics13090822
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Febrile neutropenia (FN) is a potentially severe entity, particularly in hemato-oncologic patients who have higher incidence of colonization with multidrug-resistant bacteria. Discrepancies among guidelines contribute to divergence in antimicrobial practices. Our objective was to assess the variation of practices in antimicrobial therapy in high-risk FN among Portuguese hematologists. Methods: We conducted a cross-sectional study through the implementation of an online survey, open to all clinical hematologists in the country. To characterize practice patterns regarding critical elements in FN management, three clinical vignettes were designed to describe typical situations where narrow-spectrum empiric antibiotics (vignette 1), short-course therapy (vignette 2) and de-escalation (vignette 3) could be performed. The remaining questions characterized clinical experience, department size, and differentiation and decision-making process regarding FN antibiotic therapy. Results: The survey yielded 31 responses from 11 hospitals across four regions. All respondents opted for empiric narrow-spectrum antibiotics, 22.6% opted for short-course therapy (mostly senior specialists from larger settings) and 35.5% for de-escalation (mostly young specialists). Availability of an FN protocol seemed to favor both approaches. These findings should be complemented by qualitative assessments of barriers to best practices and should support the need for interventions to improve antibiotic use in febrile neutropenia.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Cefepime Monotherapy is as Effective as Ceftriaxone Plus Amikacin in Pediatric Patients with Cancer and High-Risk Febrile Neutropenia: A Randomized Comparison
    Pires Pereira, Carlos
    Petrilli, Antonio
    Carlesse, Fabianne
    Vercillo Luisi, Flavio
    Barros da Silva, Katia
    de Martino Lee, Maria
    AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2008, 4 (04) : 237 - 243
  • [42] Importance of Risk Factors for Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified as High-Risk in Guidelines for Myeloid Growth Factor Use
    Weycker, Derek
    Li, Xiaoyan
    Barron, Rich
    Wu, Hongsheng
    Morrow, P. K.
    Xu, Hairong
    Reiner, Maureen
    Garcia, Jacob
    Mhatre, Shivani K.
    Lyman, Gary H.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (08): : 979 - +
  • [43] The cost-effectiveness of empirical antibiotic treatments for high-risk febrile neutropenic patients A decision analytic model
    Tori, Katerina
    Tansarli, Giannoula S.
    Parente, Diane M.
    Kalligeros, Markos
    Ziakas, Panayiotis D.
    Mylonakis, Eleftherios
    MEDICINE, 2020, 99 (20)
  • [44] Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children
    Aksoylar, S
    Çetingül, N
    Kantar, M
    Karapinar, D
    Kavakli, K
    Kansoy, S
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2004, 21 (02) : 115 - 123
  • [45] Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia:: A prospective, randomized, multicenter study
    Erman, M
    Akova, M
    Akan, H
    Korten, V
    Ferhanoglu, B
    Köksal, I
    Çetinkaya, Y
    Uzun, Ö
    Ünal, S
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2001, 33 (11) : 827 - 831
  • [46] Real-World Impact of Prophylactic Growth Factor Use on Timing of Febrile Neutropenia and Infection After High-Risk Chemotherapy
    Blayney, Douglas W.
    Kuderer, Nicole M.
    Joyner, Alice Kate Cummings
    Jarvis, John
    Nunag, Dominic
    Wells, Jasmine
    Huang, Lan
    Monhanlal, Ramon
    Lyman, Gary H.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (09): : 945 - +
  • [47] INCIDENCE OF ASYMPTOMATIC BACTERIURIA AND ITS RELATIONSHIP WITH BACTEREMIA DURING FEBRILE NEUTROPENIA IN THE HIGH-RISK HEMATOLOGIC PATIENT. PROSPECTIVE STUDY
    Tolosa Ridao, C.
    Villalobos Prego, M. T.
    Canet Maldonado, M.
    Mesa Tudel, A.
    Julia Arenas, M.
    Bustamante Ramirez, G.
    Lopez de la Fuente, M.
    Santiago Alonso, R.
    Muntanola Prat, A.
    Vall-llovera Calmet, F.
    Marti Tutusaus, J. M.
    Boix Palop, L.
    Sangil Betriu, A.
    Calbo Sebastian, E.
    Xercavins Valls, M.
    Gomez Garcia, L.
    HAEMATOLOGICA, 2021, 106 (10) : 315 - 316
  • [48] Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on diagnosis and antimicrobial utilization in patients with high-risk febrile neutropenia
    Koh, Kwee Choy
    Slavin, Monica A.
    Thursky, Karin A.
    Lau, Eddie
    Hicks, Rodney J.
    Drummond, Elizabeth
    Wong, Peng Shyan
    Worth, Leon J.
    LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 1889 - 1895
  • [49] Prescription of activity restriction to treat high-risk pregnancies
    Maloni, JA
    Cohen, AW
    Kane, JH
    JOURNAL OF WOMENS HEALTH, 1998, 7 (03) : 351 - 358
  • [50] High risk febrile neutropenia in acute leukemia. The experience of a public hospital
    Puga, B
    Puga, I
    Cabrera, ME
    Undurraga, MS
    Guerra, C
    Urrejola, G
    Toro, P
    REVISTA MEDICA DE CHILE, 2003, 131 (09) : 1023 - 1030